Montreal, Canada

GCP Research

Diabetic Nephropathies

Kidney Diseases

INV-202

Inversago Pharma

condition

allSponsorName

Worldwide Clinical Trials

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants with a diagnosis of Diabetic Kidney Disease due to either Type 1 diabetes mellitus or Type 2 diabetes mellitus

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

GCP Research | Montreal, Canada

Site insights

Work at this site?

Active trials

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Trial sponsors